New Key Statistics Module, Z-Score and F-Score
FRA:CD20 Key Ratios
Market Cap € M | 78.80 |
Enterprise Value € M | 84.89 |
P/E(ttm) | 12.86 |
PE Ratio without NRI | 12.86 |
Forward PE Ratio | 9.91 |
Price/Book | 4.03 |
Price/Sales | 0.84 |
Price/Free Cash Flow | 6.82 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) € M | 95.00 |
EPS (TTM) € | 0.21 |
Beneish M-Score | -3.03 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 11.51 |
EV-to-EBITDA | 11.51 |
PEG | -- |
Shares Outstanding M | 29.97 |
Net Margin (%) | 6.20 |
Operating Margin % | 7.77 |
Pre-tax Margin (%) | 6.09 |
Quick Ratio | 0.62 |
Current Ratio | 1.12 |
ROA % (ttm) | 8.13 |
ROE % (ttm) | 35.42 |
ROIC % (ttm) | 11.28 |
Dividend Yield % | -- |
Altman Z-Score | 2.57 |
FRA:CD20 Number of Guru Trades
FRA:CD20 Volume of Guru Trades
Gurus Latest Trades with FRA:CD20
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:CD20 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data